FGFR4 targeted antibodies (XOMA)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFGFR4 targeted antibodies (XOMA)
Drug Alias Namefibroblast growth factor receptor 4 targeted antibody (Xoma)ABC-4
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionFibroblast growth factor receptor 4 antagonists
TargetsFibroblast growth factor receptor 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXoma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXoma Corp
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A